Clinical Trial Update: The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the role and potential mechanisms of GLP-1 receptor agonists in coronary artery disease for patients with type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Glucagon-Like Peptide-1 Receptor Agonists, Type 2 Diabetes | Phase 4 | Status: NOT_YET_RECRUITING